GSA CAPITAL PARTNERS LLP - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 1 filers reported holding SIO GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q4 2021$215,000
-76.5%
166,806
-60.5%
0.03%
-71.0%
Q3 2021$916,000
-7.8%
422,148
+16.0%
0.09%
-17.0%
Q2 2021$993,000
+158.6%
363,887
+147.6%
0.11%
+75.0%
Q1 2021$384,000
-61.0%
146,968
-58.5%
0.06%
-60.2%
Q4 2020$985,000354,2650.16%
Other shareholders
SIO GENE THERAPIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 310,500$863,0001.79%
Consonance Capital Management LP 3,186,335$8,858,0000.83%
Opaleye Management Inc. 2,000,000$5,560,0000.73%
Sio Capital Management, LLC 886,665$2,465,0000.50%
Rubric Capital Management LP 2,335,200$6,492,0000.48%
Affinity Asset Advisors, LLC 250,000$695,0000.37%
GSA CAPITAL PARTNERS LLP 354,265$985,0000.16%
Hudson Bay Capital Management LP 3,200,000$8,896,0000.05%
Insight Advisors, LLC/ PA 24,000$67,0000.02%
Maven Securities LTD 86,788$246,0000.02%
View complete list of SIO GENE THERAPIES INC shareholders